Broad spectrum CBD contains various cannabinoids and terpenes from cannabis except THC, offering potential therapeutic effects without psychoactive properties. Full spectrum CBD contains all cannabinoids including THC (below 0.3% in legal products), potentially inducing an entourage effect for enhanced benefits like pain relief and relaxation. CBD, discovered in 1940, is renowned for its diverse therapeutic potential, influencing the endocannabinoid system to alleviate pain, anxiety, inflammation, and more.
Cannabinol (CBN) is a mildly psychoactive cannabinoid that forms when THC oxidizes over time. Found in aged cannabis, CBN is known for its potential sedative properties, aiding in sleep and relaxation. It may also possess anti-inflammatory and pain-relieving effects. Though discovered alongside THC and CBD in the 1940s, CBN's therapeutic potential is still being explored, drawing attention for its calming and potential medicinal properties.
Cannabigerol (CBG) is a non-psychoactive cannabinoid present in cannabis. Known as the "mother" or "stem cell" cannabinoid, CBG is a precursor to other cannabinoids like THC and CBD. Studies suggest CBG may have potential therapeutic effects including anti-inflammatory, neuroprotective, and antimicrobial properties. Its founding, as a compound, traces back to the discovery of cannabinoids in the 1960s, although its specific therapeutic potential has gained attention more recently.